Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 935-947

  Jarvis, W David ^a   Fornari Jr , Frank A ^a   Auer, Kelly L ^a   Freemerman, Alex J ^a   Szabo, Eva ^b   Birrer, Michael J ^b   Johnson, Charlene R ^a   Barbour, Suzanne E ^a   Dent, Paul ^a   Grant, Steven ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CERAMIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SPHINGOSINE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CYTOARCHITECTURE; DELETION MUTANT; DNA DEGRADATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; ONCOGENE C JUN; PRIORITY JOURNAL; STRESS;

EID: 0031439924     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.935     Document Type: Article

References (40)

1. Xia, Z., M. Dickens, J. Raingeaud, R. J. David, and M. E. Greenberg. Opposing effects of ERK, JNK, and RK kinases on apoptosis. Science (Washington D. C.) 270:1326-1331 (1995).
2. Jarvis, W. D., R. N., Kolesnick, F. A. Fornari, Jr., R. S. Traylor, D. A. Gewirtz, and S. Grant. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91:73-77 (1994).
3. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. A. Hannun. Cell death by ceramide. Science (Washington D. C.) 259:1769-1771 (1993).
4. Jarvis, W. D., F. A. Fornari, Jr., J. L. Browning, D. A. Gewirtz, R. N. Kolesnick, and S. Grant. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269:31658-31692 (1994).
5. Ohta, H., E. A. Sweeney, A. Masamune, Y. Yatomi, S.-I. Hakomori, and Y. Igarashi. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55: 691-697 (1995).
6. Jarvis, W. D., F. A. Fornari, Jr., R. S. Traylor, H. A. Martin, L. B. Kramer, R. K. Erukulla, R. Bittman, and S. Grant. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271:8275-8284 (1996).
7. Mathias, S., K. A. Dressier, and R. N. Kolesnick. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor-α. Proc. Natl. Acad. Sci. USA 88:10009-10013 (1992).
8. Dobrowsky, R. T., and Y. A. Hannun. Ceramide stimulates a cytosolic protein phosphatase 2A. J. Biol. Chem. 267:5048-5051 (1992).
9. Zhang, Y., B. Yao, S. Delikat, S. Bayoumy, X.-H. Lin, S. Basu, M. McGinley, P.-Y. Chan-Hui, H. Lichenstein, and R. N. Kolesnick. Kinase suppressor of ras is ceramide-activated protein kinase. Cell 89:63-72 (1997).
10. Dobrowsky, R. T., C. Kamibayishi, M. C. Mumby, and Y. A. Hannun. Ceramide activates a heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268:15523-15530 (1993).
11. Kyriakis, J. M., P. Bannerjee, E. Nikkolaki, T. Dai, E. A. Rubin, M. F. Ahmad, J. Avruch, J. R. Woodgett. The stress-activated protein kinase subfamily of c-Jun aminoterminal kinases. Nature (Lond.) 369:156-160 (1994).
12. Minden, A., T. Smeal, B. Derijard, M. Cobb, R. J. Davis, and M. Karin. c-Jun N-terminal phosphorylation correlates with the JNK subgroup, not the ERK subgroup, of mitogen-activated protein kinases. Mol. Cell. Biol. 14:6683-6688 (1994).
13. Westwick, J. K., A. E. Bielawska, G. S. Dbaibo, Y. A. Hannun, and D. A. Brenner. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270:22689-22692 (1995).
14. Verheij, M., R. Bose, X.-H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, A. Haimovitz-Friedman, Z. Y. Fuks, and R. N. Kolesnick. Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature (Lond.) 380:75-79 (1996).
15. Sawai, H., T. Okazaki, H. Yamamoto, H. Okano, Y. Takeda, M. Tashima, H. Sawada, M. Okuma, H. Ishikura, H. Umehara, and N. Domae. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270:27326-27331 (1995).
16. Westwick, J. K., C. Weitzel, A. Minden, M. Karin, and B. A. Brenner. Tumor necrosis factor-α stimulates AP-1 activity through prolonged activation of c-Jun kinase. J. Biol. Chem. 269:26396-26401 (1994).
17. Tepper, C. G., S. Jayadev, B. Liu, A. Bielawska, R. A. Wolff, S. Yonehara, Y. A. Hannun, and M. F. Seldon. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92:8443-8447 (1995).
18. Hannun, Y. A., and R. M. Bell. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science (Washington D. C.) 243:500-507 (1989).
19. Grant, S, and W. D. Jarvis. Modulation of drug-induced apoptosis by interruption of protein kinase C-dependent signal transduction pathways: evolution of a new chemotherapeutic strategy. Clin. Cancer Res. 2:1915-1920 (1996).
20. Jarvis, W. D., A. J. Turner, L. F. Povirk, R. S. Traylor, and S. Grant. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C. Cancer Res. 54:1707-1714 (1994).
21. Bertrand, R., E. Solary, P. O'Conner, K. W. Kohn, and Y. Pommier. Induction of a common pathway for apoptosis by staurosporine. Exp. Cell Res. 211:314-321 (1994).
22. Sundstrom, C., and K. Nilsson. Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cancer 17:565-577 (1976).
23. Freemerman, A. J., A. J. Turner, M. J. Birrer, E. Szabo, K. Vallerie, and S. Grant. Role of c-Jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C. Mol. Pharmacol. 49:788-795 (1996).
24. Goldkorn, T., K. A. Dressier, J. Muindi, N. S. Radin, J. Mendelsohn, D. Menaldino, D. Liotta, and R. N. Kolesnick. Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells: evidence that ceramide may mediate sphingosine action. J. Biol. Chem. 266:16092-16097 (1991).
25. Ohta, H., Y. Yatomi, E. A. Sweeney, S.-I. Hakomori, and Y. Igarashi. A possible role for sphingosine in induction of apoptosis by tumor necrosis factor in human neutrophils. FEBS Lett. 355:267-270 (1994).
26. Brown, P. H., T. K. Chen, and M. J. Birrer. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791-797 (1994).
27. 2 is phosphorylated and activated by MAPK. Cell 72:269-278 (1993).
28. 2 and cyclooxygenase 2. Biochem. Biophys. Res. Commun. 220:681-686 (1996).
29. Chao, R., W. A. Khan, and Y. A. Hannun. Retinoblastoma gene product dephosphorylation induced by D-erythro-sphingosine. J. Biol. Chem. 267: 23459-23462 (1992).
30. Pushkareva, M., R. Chao, A. Bielawska, A. H. Merrill, Jr., M. Cromwell, B. Lagen, B. Liotta, and Hannun, Y. A. Stereoselectivity of induction of retinoblastoma gene product (pRb) dephosphorylation by D-erythro-sphingosine: a role of pRb in growth suppression by sphingosine. Biochemistry 34:1885-1892 (1994).
31. Dbaibo, G. S., M. Y. Pushkareva, S. Jayadev, J. K. Schwarz, J. M. Horowitz, L. M. Obeid, and Y. A. Hannun. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. USA 92:1347-1355 (1995).
32. Wolff, R. A., R. T. Dobrowsky, A. Bielawska, L. M. Obeid, and Y. A. Hannun. Role of ceramide-activated protein phosphatase in ceramide-mediated signal transduction. J. Biol. Chem. 269:19605-19609 (1994).
33. Jarvis, W. D., S. Grant, and R. N. Kolesnick. Ceramide and the induction of apoptosis. Clin. Cancer Res. 2:1-6 (1996).
34. Raines, M. A., D. W Golde, and R. N. Kolesnick. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268:14572-14575 (1993).
35. Jones, M. J., and A. W. Murray. Evidence that ceramide selectively inhibits protein kinase C-α translocation. J. Biol. Chem 270:5007-5013 (1995).
36. Lee, J. Y., and Y. A. Hannun. Ceramide inactivates cellular cPKCα. J. Biol. Chem. 271:13169-13174 (1996).
37. Cuvillier, O., S. Pirianov, B. Kleuser, P. G. Vanik, O. A. Coso, S. Gutkind, and S. Spiegel. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature (Lond.) 381:800-803 (1996).
38. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. Differential activation of ERK and JNK protein kinases by Raf-1 and MEKK. Science (Washington D. C.) 266:1719-1723 (1994).
39. Coroneos, E., Y. Wang, J. R. Panushka, D. J. Templeton, and M. Kester. Sphingolipid metabolites differentially regulate mitogen-regulated and stress-activated protein kinase cascades. Biochem. J. 316:13-17 (1996).
40. Pyne, S., S. Chapman, and N. J. Pyne. Sphingomyelin-derived lipids differentially regulate the extracellular signal-regulated kinase and Jun N-terminal kinase signal cascades. Eur. J. Biochem. 237:819-826 (1996).